Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Amalia, Anastasopoulou"'
Autor:
Georgios Lyrarakis, Michael Liontos, Amalia Anastasopoulou, Spyridon Bouros, Aikaterini Gkoufa, Panagiotis Diamantopoulos, Helen Gogas, Dimitrios C. Ziogas
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
BackgroundProgrammed cell death 1 receptor (PD-1) inhibition as monotherapy followed by Cytotoxic T-lymphocyte associated protein 4 (CTLA-4) inhibition in case of progression or as upfront double co-inhibition has drastically improved the survival ou
Externí odkaz:
https://doaj.org/article/56b832ae564d4fb7a894225d563b1abb
Autor:
Anna Angelousi, Dimitrios C. Ziogas, Vasiliki Siampanopoulou, Chrysoula Mytareli, Amalia Anastasopoulou, George Lyrarakis, Helen Gogas
Publikováno v:
Diseases, Vol 12, Iss 2, p 40 (2024)
Background: Checkpoint inhibitor (CPI)-associated diabetes mellitus (CPI-DM) is a rare immune-related adverse event (irAE) that presents with variable clinical manifestations. Data about its pathogenesis have not yet been adequately studied. Methods:
Externí odkaz:
https://doaj.org/article/bf013408c1de4f2ea79459ba335d95b0
Autor:
Ioannis-Alexios Koumprentziotis, Charalampos Theocharopoulos, Dimitra Foteinou, Erasmia Angeli, Amalia Anastasopoulou, Helen Gogas, Dimitrios C. Ziogas
Publikováno v:
Vaccines, Vol 12, Iss 1, p 54 (2024)
Immune checkpoints (ICs) are molecules implicated in the fine-tuning of immune response via co-inhibitory or co-stimulatory signals, and serve to secure minimized host damage. Targeting ICs with various therapeutic modalities, including checkpoint in
Externí odkaz:
https://doaj.org/article/d5ce8c95cb3348eb828196dd87d0b9df
Autor:
Panagiotis T Diamantopoulos, Amalia Anastasopoulou, Maria Dimopoulou, Michalis Samarkos, Helen Gogas
Publikováno v:
Therapeutic Advances in Hematology, Vol 14 (2023)
Patients with sickle cell disease (SCD) suffer from complications due to anemia, inflammation, and vaso-occlusion. Factors that trigger sickling and/or inflammation may initiate such complications, while treatment with hydroxyurea (HU) reduces their
Externí odkaz:
https://doaj.org/article/58f90757d6364a30953ddfe06cfe443d
Autor:
Mariam Markouli, Sevastianos Chatzidavid, Dimitra Vlachopoulou, Nefeli Giannakopoulou, Amalia Anastasopoulou, Nora-Athina Viniou, Panagiotis Diamantopoulos
Publikováno v:
Mediterranean Journal of Hematology and Infectious Diseases, Vol 14, Iss 1 (2022)
Bacillus cereus is a Gram-positive rod that can cause food intoxication, localized infection, or bacteremia with potential organ involvement (e.g., meningitis, cerebral and liver abscesses, pneumonia, etc.). Patients with neutropenia and/or hematolog
Externí odkaz:
https://doaj.org/article/e9c0ae4f2d3d48e4ba328d6b510980bb
Autor:
Amalia Anastasopoulou, Panagiotis T. Diamantopoulos, Chrysanthi Skalioti, George Liapis, Eleni Psychogiou, Dimitrios C. Ziogas, Helen Gogas
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Sarcoidosis and sarcoid-like reactions (SLR) have been repeatedly reported in patients with melanoma treated with BRAF and MEK inhibitors. In the current study we present three patients that developed SLR under treatment with BRAF and mitogen-activat
Externí odkaz:
https://doaj.org/article/e3a8c47cf68b4dab9fe35eec742176df
Autor:
Christos Stafylidis, Panagiotis Diamantopoulos, Eleni Athanasoula, Elena Solomou, Amalia Anastasopoulou
Publikováno v:
Journal of Fungi, Vol 8, Iss 11, p 1127 (2022)
Acute lymphoblastic leukemia (ALL) patients comprise a highly immunocompromised group due to factors associated either with the treatment or the disease itself. Invasive mold infections (IMIs) are considered to be responsible for higher morbidity and
Externí odkaz:
https://doaj.org/article/f3d35fbc747c468ca6d0d8e18bad5e8d
Autor:
Eva Kassi, Anna Angelousi, Nikolaos Asonitis, Panagiotis Diamantopoulos, Amalia Anastasopoulou, George Papaxoinis, Michalis Kokkinos, Ilias Giovanopoulos, Georgios Kyriakakis, Fotini Petychaki, Akrivi Savelli, Olga Benopoulou, Helen Gogas
Publikováno v:
Cancer Medicine, Vol 8, Iss 15, Pp 6585-6594 (2019)
Abstract Background Immune‐checkpoint inhibitors have been shown to improve survival in melanoma patients, but can also trigger immune‐related endocrinopathies, especially hypophysitis and thyroid dysfunction. Methods To assess the incidence and
Externí odkaz:
https://doaj.org/article/88f70327b1b84cc9a60ca58e3cd64a66
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)
Abstract Immune checkpoint inhibitors (ICBs) have revolutionized cancer treatment producing remarkable and durable responses for a range of malignancies. However, the additional modulation of immune response by ICBs may rarely cause immune-related in
Externí odkaz:
https://doaj.org/article/7067f65aea87429b918e45dbcd47f0bb
Autor:
John Haanen, Amalia Anastasopoulou, Helen Gogas, Frosso Kostantinou, Evangelos Cholongitas, Panagiotis Diamantopoulos
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
In the evolving immune-oncology landscape, numerous patients with cancer are constantly treated with immune checkpoint inhibitors (ICPIs) but among them, only sporadic cases with pre-existing hepatitis B virus (HBV) and hepatitis C virus (HCV) are re
Externí odkaz:
https://doaj.org/article/f3259fe279f14b3f9eb240a1a17bed7e